Envista Holdings Corp- 详细介绍、公司背景、业务范围、财务数据以及市场表现

关于 Envista Holdings Corp 公司

Envista Holdings Corporation is a global dental products company. The Company's diversified portfolio of solutions covers a range of dentists' clinical needs for preventing, diagnosing, and treating dental conditions as well as improving the aesthetics of the human smile. It has more than 30 dental brands, including Nobel Biocare, Ormco, DEXIS and Kerr. Its segments include Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment primarily develops, manufactures and markets dental implant systems, including regenerative solutions, dental prosthetics and associated treatment software and technologies, as well as orthodontic bracket systems, aligners and lab products. The Equipment & Consumables segment primarily develops, manufactures, and markets dental equipment and supplies used in dental offices, including digital imaging systems, software, and other visualization/magnification systems; and endodontic systems and related products.

Envista Holdings Corp简介



公司代码NVST

公司名称Envista Holdings Corp

上市日期Sep 18, 2019

CEOKeel (Paul A)

员工数量12300

证券类型Ordinary Share

年结日Sep 18

公司地址200 S. Kraemer Blvd., Bldg. E

城市BREA

上市交易所NASDAQ OMX NASDAQ Basic NYSE

国家United States of America

邮编92821

电话17148175418

网址https://envistaco.com/en

公司代码NVST

上市日期Sep 18, 2019

CEOKeel (Paul A)

Envista Holdings Corp公司高管



名称

名称/职务

职务

持股

持股变动

Mr. Paul A. Keel

President, Chief Executive Officer, Director

167.63K

+58.15%

Mr. Stefan Nilsson

President - Nobel Biocare

62.36K

+11.90%

Mr. Mark E. Nance

Senior Vice President, General Counsel, Secretary

56.88K

+9.83%

Ms. Wendy Carruthers

Independent Director

40.16K

-26.02%

Ms. Christine A. Tsingos

Independent Director

40.15K

-26.03%

Mr. Daniel A. Raskas, J.D.

Independent Director

34.23K

-30.53%

Mr. Vivek Jain

Independent Director

33.16K

-31.51%

Ms. Veronica Acurio

President - Orthodontics

11.75K

-381.11%

Mr. Mischa M. Reis

Senior Vice President - Strategy and Corporate Development

--

Mr. R. Scott (Scott) Huennekens

Independent Chairman of the Board

--

名称

名称/职务

职务

持股

持股变动

Mr. Paul A. Keel

President, Chief Executive Officer, Director

167.63K

+58.15%

Mr. Stefan Nilsson

President - Nobel Biocare

62.36K

+11.90%

Mr. Mark E. Nance

Senior Vice President, General Counsel, Secretary

56.88K

+9.83%

Ms. Wendy Carruthers

Independent Director

40.16K

-26.02%

Ms. Christine A. Tsingos

Independent Director

40.15K

-26.03%

Mr. Daniel A. Raskas, J.D.

Independent Director

34.23K

-30.53%

收入明细

单位: USD更新时间: 4月6日周一

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

由于公司未披露，未能获取相关数据

地区USD

名称

营收

占比

United States

1.28B

47.12%

All Other

1.24B

45.74%

China

194.40M

7.15%

业务

地区

由于公司未披露，未能获取相关数据

股东统计

更新时间: 5 小时前

持股股东

股东类型

持股股东

占比

BlackRock Institutional Trust Company, N.A.

8.63%

Ariel Investments, LLC

7.36%

Dimensional Fund Advisors, L.P.

6.01%

Franklin Mutual Advisers, LLC

4.91%

Vanguard Portfolio Management, LLC

4.65%

其他

68.45%

持股股东

占比

BlackRock Institutional Trust Company, N.A.

8.63%

Ariel Investments, LLC

7.36%

Dimensional Fund Advisors, L.P.

6.01%

Franklin Mutual Advisers, LLC

4.91%

Vanguard Portfolio Management, LLC

4.65%

其他

68.45%

股东类型

持股股东

占比

Investment Advisor

63.03%

Investment Advisor/Hedge Fund

45.04%

Hedge Fund

11.93%

Pension Fund

1.41%

Sovereign Wealth Fund

1.36%

Research Firm

1.31%

Bank and Trust

0.56%

Individual Investor

0.48%

Private Equity

0.36%

机构持股



更新时间: 4月1日周三

报告期

机构数

持股数

持股占比

持股变动

2026Q1

711

203.45M

125.03%

-3.29M

2025Q4

698

191.18M

116.72%

-29.60M

2025Q3

713

196.49M

119.50%

-31.47M

2025Q2

735

199.63M

120.11%

-32.52M

2025Q1

767

200.87M

118.49%

-32.33M

2024Q4

774

200.73M

116.58%

-32.33M

2024Q3

769

198.37M

115.33%

-28.47M

2024Q2

775

193.95M

112.83%

-33.23M

2024Q1

793

187.23M

108.93%

-31.14M

2023Q4

800

189.02M

110.25%

-16.86M

股东持股明细



名称

持股数

占比

持股变动

变动比例

公告日期

BlackRock Institutional Trust Company, N.A.

14.04M

8.57%

-276.49K

-1.93%

Dec 31, 2025

Ariel Investments, LLC

11.97M

7.3%

-33.66K

-0.28%

Dec 31, 2025

Dimensional Fund Advisors, L.P.

9.63M

5.88%

+90.59K

+0.95%

Dec 31, 2025

Franklin Mutual Advisers, LLC

7.99M

4.87%

-705.06K

-8.11%

Dec 31, 2025

Atlanta Capital Management Company, L.L.C.

7.38M

4.5%

-1.29M

-14.85%

Dec 31, 2025

Victory Capital Management Inc.

6.06M

3.7%

+146.75K

+2.48%

Dec 31, 2025

AllianceBernstein L.P.

6.04M

3.68%

-62.95K

-1.03%

Dec 31, 2025

Gates Capital Management, Inc.

5.81M

3.54%

-414.85K

-6.67%

Dec 31, 2025

持股ETF



更新时间: 12月2日周二

机构名称

占比

State Street SPDR S&P Health Care Equipment ETF

1.75%

Schwab Ariel Opportunities ETF

1.51%

Pacer US Export Leaders ETF

0.88%

Distillate Small/Mid Cash Flow ETF

0.58%

Royce Quant Small-Cap Quality Value ETF

0.5%

Harbor Long-Short Equity ETF

0.45%

First Trust Health Care Alphadex Fund

0.41%

iShares U.S. Medical Devices ETF

0.4%

VictoryShares US Small Mid Cap Value Momentum ETF

0.3%

DFA Dimensional US Small Cap Value ETF

0.27%

State Street SPDR S&P Health Care Equipment ETF

占比1.75%

Schwab Ariel Opportunities ETF

占比1.51%

Pacer US Export Leaders ETF

占比0.88%

Distillate Small/Mid Cash Flow ETF

占比0.58%

Royce Quant Small-Cap Quality Value ETF

占比0.5%

Harbor Long-Short Equity ETF

占比0.45%

First Trust Health Care Alphadex Fund

占比0.41%

iShares U.S. Medical Devices ETF

占比0.4%

VictoryShares US Small Mid Cap Value Momentum ETF

占比0.3%

DFA Dimensional US Small Cap Value ETF

占比0.27%

分红派息



近5年累计派现 0.00 美元

公告日期

分红计划

股权登记日

现金发放日

除权除息日

暂无数据

拆合股



公告日期

除权除息日

类型

比率

暂无数据

公告日期

除权除息日

类型

比率

暂无数据